David H. Mack
2022
In 2022, David H. Mack earned a total compensation of $3.6M as President, Chief Executive Officer and Director at PMV Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,275 |
|---|---|
| Option Awards | $2,814,415 |
| Salary | $563,750 |
| Total | $3,576,440 |
Mack received $2.8M in option awards, accounting for 79% of the total pay in 2022.
Mack also received $198.3K in non-equity incentive plan and $563.8K in salary.
Rankings
In 2022, David H. Mack's compensation ranked 995th out of 5,732 executives tracked by ExecPay. In other words, Mack earned more than 82.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 995 out of 5,732 | 83rd |
Division Manufacturing | 467 out of 3,121 | 85th |
Major group Chemicals And Allied Products | 168 out of 1,416 | 88th |
Industry group Drugs | 151 out of 1,317 | 89th |
Industry Pharmaceutical Preparations | 110 out of 963 | 89th |
Source: SEC filing on April 28, 2023.
Mack's colleagues
We found two more compensation records of executives who worked with David H. Mack at PMV Pharmaceuticals in 2022.